H. Lee Moffit Cancer Center

Tampa, Florida 33612

0 studies enrolling now · 4 studies all time

What they study most

Colorectal Carcinoma, Follicular Lymphoma (FL), Marginal Zone Lymphoma, Metastatic Pancreatic Cancer, Multiple Myeloma, Non Hodgkin Lymphoma

Studies at this site

• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer — Completed
• CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma — Completed
• Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma — Completed